In 2022, juries convicted Elizabeth Holmes and Ramesh "Sunny" Balwani of fraud tied to Theranos. This case file walks through the red flags an auditor would have checked: revenue projections versus actual revenue, the stalled Walgreens rollout, pharmaceutical "validation" reports, military claims, and the federal lab inspection.
Allegations are attributed to the agencies that made them. General information, not financial advice.
Sources: SEC press release 2018-41 and complaint, SEC v. Holmes and Theranos, Inc. (N.D. Cal., 14 Mar 2018). U.S. Attorney's Office, N.D. Cal.: U.S. v. Holmes et al., 18-CR-00258-EJD, and press releases (4 Jan 2022; 7 Jul 2022). Verdict form, ECF No. 1235 (3 Jan 2022). Ninth Circuit opinion, Nos. 23-1040, 23-1166, 23-1167 (24 Feb 2025). CMS letter to Theranos (25 Jan 2016). Order Granting Motion for Modification of Sentence, ECF No. 1816, and Balwani Second Amended Judgment, ECF No. 1814 (26 Mar 2026). U.S. Supreme Court docket No. 25-1330. The Wall Street Journal (Oct 2015). Reuters (24 Feb 2025).
Narrated with a synthetic AI voice; researched and fact-checked from public records.
Chapters:
0:00 Intro
0:24 The verdict
1:21 The promise
2:19 The retail deals
4:45 The projections
6:25 The stalled rollout
7:40 The logos and the battlefield
8:35 The control and the regulator
10:18 The lab
11:13 The reckoning
12:17 Where it stands
13:03 Sources and close